BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32198408)

  • 21. T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.
    Perri A; Catalano S; Bonofiglio D; Vizza D; Rovito D; Qi H; Aquila S; Panza S; Rizza P; Lanzino M; Andò S
    Mol Cell Endocrinol; 2014 Jan; 382(1):205-217. PubMed ID: 24121026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Mikami M; Taniguchi H; Takahashi T; Adachi Y; Imamura A; Imai K; Shinomura Y
    Eur J Cancer; 2006 Sep; 42(14):2374-81. PubMed ID: 16809031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-744-5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells.
    Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zheng J; Lu X
    Exp Cell Res; 2020 Jul; 392(1):112024. PubMed ID: 32335029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
    Balta AZ; Filiz AI; Kurt Y; Sucullu I; Yucel E; Akin ML
    Med Oncol; 2012 Jun; 29(2):734-41. PubMed ID: 21547408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
    Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
    Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest.
    Koehler A; Schlupf J; Schneider M; Kraft B; Winter C; Kashef J
    Dev Biol; 2013 Nov; 383(1):132-45. PubMed ID: 23958437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
    He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
    Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
    Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of hepatic stem cell line stably expressing HBx protein and the effect of HBx on cell proliferation].
    Lu Y; Shen L; Li H; Hu D; Zhang X; Hu B; Feng T; Huang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):256-60. PubMed ID: 23643081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer.
    Shibata M; Inaishi T; Ichikawa T; Shimizu D; Soeda I; Takano Y; Takeuchi D; Tsunoda N; Kikumori T
    Surg Today; 2021 Oct; 51(10):1703-1712. PubMed ID: 33733290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
    Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
    Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
    Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
    ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR-Seq Identifies Distinct Repertoires of Distant-Metastatic and Nondistant-Metastatic Thyroid Tumors.
    Lan X; Cao J; Ye K; Zhang C; Zhang Q; Ge X; Wang C; Zhang C; Tai Z; Wei W; Huang Y; Yi X; Tan Z; Zheng C; Chen C; Zhu X; Wang J; Xu J; Zhu X; Ge M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32674137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.